Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Clinical trial NCT04012827 · UNKNOWN
Trial details
- NCT number
- NCT04012827
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-20
- Primary completion
- 2023-06-15
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.